ACE PHARMA
ActiveSummary
ACE PHARMA has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €221,792 and a net result of €1,837. Equity remains stable across the filed financial years (±2.2% per year). Its solvency ranks better than 85% of 22,080 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
06-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Weakest financial yearnet €1,837 ▼54%
Net result drops to €1,837, the lowest in the series.
03-07
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
20-03
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
03-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
24-06
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
07-06
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
31-12
Financial
Equity above €200,000equity €210,481 ▲7.9%
A profit in every financial year since 2018 builds equity to €210,481.
08-07
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
04-06
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
15-06
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
13-06
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 37 annual accounts filed, the latest 10 are here; all 37 are under Financials.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.